Cardiogenic shock (CS) remains the most common cause of death in patients with acute
myocardial infarction although mortality could be reduced from formerly∼ 80% to 40–50 …

• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

The aim of this study was to evaluate the value of microvascular obstruction (MO) and infarct
size as a percentage of left ventricular mass (IS% LV), as measured by contrast-enhanced …

Background In patients who have acute myocardial infarction with cardiogenic shock, early
revascularization of the culprit artery by means of percutaneous coronary intervention (PCI) …

Background: Data suggest that T1 and T2 mapping have excellent diagnostic accuracy in
patients with suspected myocarditis. However, the true diagnostic performance of …

Background: Although the prognostic value of findings from cardiac magnetic resonance
(CMR) imaging has been established in single-center center studies in patients with ST …

Aims Evidence on the impact on clinical outcome of active mechanical circulatory support
(MCS) devices in cardiogenic shock (CS) is scarce. This collaborative meta-analysis of …

Objectives: The goal of this study was to assess the diagnostic performance of cardiac
magnetic resonance (CMR) compared with endomyocardial biopsy in patients with …

Aims Microvascular obstruction (MVO) is the underlying cause for the no-reflow
phenomenon in ST-segment elevation myocardial infarction (STEMI). The association …

Background: Mortality in cardiogenic shock (CS) remains high. Early risk stratification is
crucial to make adequate treatment decisions. Objectives: This study sought to develop an …